In RA, as previously discussed, VNS has been shown to suppress key cytokines such as TNF—a common therapeutic target of many biologics—indicating that bioelectronic stimulation may complement or even reduce the required dosage of anticytokine antibody therapies [800]. The gene discussed is TNF; the disease is rheumatoid arthritis.